AstraZeneca strikes $1 billion deal for rare-disease drug maker

AstraZeneca on Thursday struck a $1 billion deal to buy a maker of drug for rare diseases, further building out the capabilities it acquired in the 2021 deal for Alexion Pharmaceuticals.
Source: Reuters: Health - Category: Consumer Health News Source Type: news